DRKS00031228CompletedNot Applicable
Snap Shot Audit Early Onset Colorectal Cancer - Are we doing enough or can we do more? - EOCC
Clarunis – Universitäres Bauchzentrum Basel0 sites650 target enrollmentStarted: April 19, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 650
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •new diagnosed colorectal carcinoma which qualifies for oncological therapy (palliative therapies included)
- •- Patients who have consented to the further use of their clinical data for research (general consent granted)
Exclusion Criteria
- •- the colorectal carcinoma has not been confirmed
- •- the colorectal carcinoma was not defined as a primary carcinoma (e.g. colorectal metastasis of another underlying tumor disease)
- •- Missing general consent
Investigators
Similar Trials
Active, not recruiting
Unknown
Early screening for colorectal cancer via a simple blood sampleCancerColorectal cancerISRCTN15583857Centre Hospitalier Universitaire de Liège1,900
Completed
Not Applicable
Early diagnosis of colorectal cancer by faecal occult blood detection - the Goteborg trialColorectal cancerCancerISRCTN58825135Swedish Cancer Society (Sweden)68,000
Active, not recruiting
Not Applicable
Detection of bowel cancer using urinary biomarkersCancerColorectal cancerISRCTN39793686Yeovil District Hospital NHS Foundation Trust600
Not yet recruiting
Not Applicable
Early Detection of Colorectal Cancer Using Liquid BiopsyNeoplasmsKCT0006319Asan Medical Center500
Completed
Not Applicable
The novel diagnostic method of colorectal cancer by methyl mercaptaThe novel diagnostic method for colorectal cancer: Detection of methyl-mercaptan from flatus.JPRN-UMIN000028256Yokohama City University50